MedicalResearch.com Interview with: Dr. Larry Kosinski, MD Gastroenterologist and SonarMD Founder & Board Member MedicalResearch.com: What is the background for this study? Would you briefly explain what is meant by the IBD group of diseases? Response:  Affecting up to 70 million Americans, the U.S. spends $136 billion each year on digestive health as these conditions are complex to predict, treat and manage. Inflammatory Bowel Disease (IBD) includes people specifically diagnosed with either ulcerative colitis or Crohn’s disease, and these conditions require close monitoring to reduce the risk for complications that lead to lengthy hospital stays and significant medical spend. In addition to providing a holistic health program, the SonarMD digital platform risk stratifies patients and performs continuous symptom checks to identify deteriorating symptoms sooner and communicate changes to physicians, meaning that care teams can intervene faster to keep patients healthier and lower the overall cost of care. The two large, longitudinal studies that we presented at Digestive Disease Week 2024 evaluated several major drivers of medical costs in people living with IBD and enrolled in the SonarMD end-to-end, digital care coordination program to determine if SonarMD’s program reduced healthcare utilization and concurrently produced better health outcomes. To assess this, we looked at Emergency Department visits and In-patient Admissions compared to risk-matched control groups. (more…)